title: What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma?
authors.affiliation: Liver Transplant Unit, Henri Mondor Hospital AP-HP, Paris-Est Créteil University, Créteil, France. christophe.duvoux@hmn.aphp.fr
authors.forename: Christophe
authors.initials: C
authors.lastname: Duvoux
authors.forename: Tetsuya
authors.initials: T
authors.lastname: Kiuchi
authors.forename: Bernhard
authors.initials: B
authors.lastname: Pestalozzi
authors.forename: Ronald
authors.initials: R
authors.lastname: Busuttil
authors.forename: Rebecca
authors.initials: R
authors.lastname: Miksad
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000401:mortality / Q000556:secondary / Q000601:surgery / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D019317:Evidence-Based Medicine; D006305:Health Status Indicators; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D016031:Liver Transplantation / Q000009:adverse effects / Q000401:mortality; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome